Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$10.91 2.54%
Market Cap
$92.2M
Price Target
Refer to Report
Volume
1.7K
52wk Range
$6.34 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.